JENTADUETO XR

Linagliptin and metformin hydrochloride · Boehringer Ingelheim Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for JENTADUETO XR, covering 2016-05-27 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: JENTADUETO XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)